Abstract Details
|
Ronald M. Lazar, PhD, FAHA, FÂé¶¹´«Ã½Ó³»
(University of Alabama At Birmingham)
PRESENTER |
Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care. |
| Lauren E. Dunn, MD (Ochsner Health System) | Dr. Dunn has nothing to disclose. |
| No disclosure on file | |
| Pascal Maisonobe | Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen. |
| No disclosure on file | |
| Andrea Lendaris, MD, MS (Icahn School of Medicine at Mount Sinai) | Dr. Lendaris has nothing to disclose. |
| Randolph S. Marshall, MD, FÂé¶¹´«Ã½Ó³» (Columbia University) | The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care. |